ADV FUNCT MATER 润色咨询

ADVANCED FUNCTIONAL MATERIALS

出版年份:2001 年文章数:11578 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:3.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1099067, encodeId=9120109906e7a, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099068, encodeId=180210990682c, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970108, encodeId=81979e01080e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:许个愿,有消息了会还愿<br>3月5号,投稿<br>4月29号,拒稿,建议转投<br>5月23号,二投<br>等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ebd35496006, createdName=ms3000001632795408, createdTime=Tue Jun 01 17:20:03 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013133, encodeId=b45910131332c, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:可穿戴能源;汗液;传感<br>经验分享:editor-in-chief: joern ritterbusch。。。确实,搞得同样的问题,十多天没送审,然后让转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06502182349, createdName=12076f1am80(暂无昵称), createdTime=Tue Aug 31 10:23:04 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859755, encodeId=3859859e5593, content=为什么你们效率都那么快,投了还有3个半小时就14天了,看经验原以为这么久差不多已经送审了,结果这快14天的时候编辑才来信建议转投。我吐了,我好难!编辑是editor-in-chief: joern ritterbusch。建议转投的期刊也是他是editor-in-chief,是新出的wiley期刊,if还没有。我哭辽。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Thu Apr 23 14:05:45 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861953, encodeId=658786195320, content=审稿速度:3.0<br>经验分享:投稿后14天送审,三个月后返回审稿意见,三个大修。两周后返回隔天接收。<br> 总体来讲afm喜欢追热点材料,对机理和创新性要求并不高,同级别里面,个人跟喜欢acs nano的质量。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Jun 16 04:55:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996459, encodeId=05279964597a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:5.20投稿(出审稿意见前,一直显示under consideration)<br>6.15返修(两个小修,一个大修,给10天修改)<br>6.24提交返修稿<br>7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d35541911, createdName=ms8000001728757183, createdTime=Mon Jul 05 16:26:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850962, encodeId=1bfc8509626c, content=18年12月底投am,1月8号建议转投afm<br> 转投后两个月审稿意见还没回来,写信催,告诉我还在审稿人手里<br> 3月12号被拒,一个vip,一个大修,一个拒稿,说我们没有创新,编辑拒稿<br> 申诉,一周后从拒稿转为大修,3月26号投出去,到现在还没有消息。。。<br> 只能说太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Mon Apr 22 10:53:02 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861652, encodeId=cb76861652c1, content=2020.5.15 投稿<br> 2020.6.02 出审稿意见,一大修,一小修,编辑给大修<br> 2020.6.07 提交修改稿<br> 2020.6.09 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Tue Jun 09 21:59:43 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858357, encodeId=f58585835ecd, content=2019-12-4 投稿<br> 2019-12-24 审稿意见回来。三个审稿人,2个小修,一个拒稿,说创新性不足。编辑拒稿。<br> 2019-12-24 老板不服,上诉argue。<br> 2020-01-30 编辑回信,上诉成功,稿件状态由拒稿变为大修,给了10天修改时间,明确说还会 <br> 再次送审。<br> 2020-2-8 提交返修稿,按照审稿人要求修改了论文和补充了实验。<br> 2020-2-20 接受。不需要再修改。<br> 2020-3-6 proof<br> 2020-3-12 online<br> 总的来说,觉得自己文章有亮点,就要敢于争取。做的是介入光动力学治疗这一块的,希望大家多多引用(doi: 10.1002/adfm.201910084)。最后希望全世界的新冠疫情早点结束。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Mar 13 18:27:32 CST 2020, time=2020-03-13, status=1, ipAttribution=)]
    2021-12-28 Gym璨烨

    选刊时有哪些需要避免的雷区?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1099067, encodeId=9120109906e7a, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099068, encodeId=180210990682c, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970108, encodeId=81979e01080e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:许个愿,有消息了会还愿<br>3月5号,投稿<br>4月29号,拒稿,建议转投<br>5月23号,二投<br>等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ebd35496006, createdName=ms3000001632795408, createdTime=Tue Jun 01 17:20:03 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013133, encodeId=b45910131332c, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:可穿戴能源;汗液;传感<br>经验分享:editor-in-chief: joern ritterbusch。。。确实,搞得同样的问题,十多天没送审,然后让转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06502182349, createdName=12076f1am80(暂无昵称), createdTime=Tue Aug 31 10:23:04 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859755, encodeId=3859859e5593, content=为什么你们效率都那么快,投了还有3个半小时就14天了,看经验原以为这么久差不多已经送审了,结果这快14天的时候编辑才来信建议转投。我吐了,我好难!编辑是editor-in-chief: joern ritterbusch。建议转投的期刊也是他是editor-in-chief,是新出的wiley期刊,if还没有。我哭辽。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Thu Apr 23 14:05:45 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861953, encodeId=658786195320, content=审稿速度:3.0<br>经验分享:投稿后14天送审,三个月后返回审稿意见,三个大修。两周后返回隔天接收。<br> 总体来讲afm喜欢追热点材料,对机理和创新性要求并不高,同级别里面,个人跟喜欢acs nano的质量。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Jun 16 04:55:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996459, encodeId=05279964597a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:5.20投稿(出审稿意见前,一直显示under consideration)<br>6.15返修(两个小修,一个大修,给10天修改)<br>6.24提交返修稿<br>7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d35541911, createdName=ms8000001728757183, createdTime=Mon Jul 05 16:26:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850962, encodeId=1bfc8509626c, content=18年12月底投am,1月8号建议转投afm<br> 转投后两个月审稿意见还没回来,写信催,告诉我还在审稿人手里<br> 3月12号被拒,一个vip,一个大修,一个拒稿,说我们没有创新,编辑拒稿<br> 申诉,一周后从拒稿转为大修,3月26号投出去,到现在还没有消息。。。<br> 只能说太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Mon Apr 22 10:53:02 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861652, encodeId=cb76861652c1, content=2020.5.15 投稿<br> 2020.6.02 出审稿意见,一大修,一小修,编辑给大修<br> 2020.6.07 提交修改稿<br> 2020.6.09 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Tue Jun 09 21:59:43 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858357, encodeId=f58585835ecd, content=2019-12-4 投稿<br> 2019-12-24 审稿意见回来。三个审稿人,2个小修,一个拒稿,说创新性不足。编辑拒稿。<br> 2019-12-24 老板不服,上诉argue。<br> 2020-01-30 编辑回信,上诉成功,稿件状态由拒稿变为大修,给了10天修改时间,明确说还会 <br> 再次送审。<br> 2020-2-8 提交返修稿,按照审稿人要求修改了论文和补充了实验。<br> 2020-2-20 接受。不需要再修改。<br> 2020-3-6 proof<br> 2020-3-12 online<br> 总的来说,觉得自己文章有亮点,就要敢于争取。做的是介入光动力学治疗这一块的,希望大家多多引用(doi: 10.1002/adfm.201910084)。最后希望全世界的新冠疫情早点结束。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Mar 13 18:27:32 CST 2020, time=2020-03-13, status=1, ipAttribution=)]
    2021-12-28 Mia

    哪些期刊是公认的水刊?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1099067, encodeId=9120109906e7a, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099068, encodeId=180210990682c, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970108, encodeId=81979e01080e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:许个愿,有消息了会还愿<br>3月5号,投稿<br>4月29号,拒稿,建议转投<br>5月23号,二投<br>等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ebd35496006, createdName=ms3000001632795408, createdTime=Tue Jun 01 17:20:03 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013133, encodeId=b45910131332c, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:可穿戴能源;汗液;传感<br>经验分享:editor-in-chief: joern ritterbusch。。。确实,搞得同样的问题,十多天没送审,然后让转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06502182349, createdName=12076f1am80(暂无昵称), createdTime=Tue Aug 31 10:23:04 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859755, encodeId=3859859e5593, content=为什么你们效率都那么快,投了还有3个半小时就14天了,看经验原以为这么久差不多已经送审了,结果这快14天的时候编辑才来信建议转投。我吐了,我好难!编辑是editor-in-chief: joern ritterbusch。建议转投的期刊也是他是editor-in-chief,是新出的wiley期刊,if还没有。我哭辽。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Thu Apr 23 14:05:45 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861953, encodeId=658786195320, content=审稿速度:3.0<br>经验分享:投稿后14天送审,三个月后返回审稿意见,三个大修。两周后返回隔天接收。<br> 总体来讲afm喜欢追热点材料,对机理和创新性要求并不高,同级别里面,个人跟喜欢acs nano的质量。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Jun 16 04:55:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996459, encodeId=05279964597a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:5.20投稿(出审稿意见前,一直显示under consideration)<br>6.15返修(两个小修,一个大修,给10天修改)<br>6.24提交返修稿<br>7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d35541911, createdName=ms8000001728757183, createdTime=Mon Jul 05 16:26:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850962, encodeId=1bfc8509626c, content=18年12月底投am,1月8号建议转投afm<br> 转投后两个月审稿意见还没回来,写信催,告诉我还在审稿人手里<br> 3月12号被拒,一个vip,一个大修,一个拒稿,说我们没有创新,编辑拒稿<br> 申诉,一周后从拒稿转为大修,3月26号投出去,到现在还没有消息。。。<br> 只能说太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Mon Apr 22 10:53:02 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861652, encodeId=cb76861652c1, content=2020.5.15 投稿<br> 2020.6.02 出审稿意见,一大修,一小修,编辑给大修<br> 2020.6.07 提交修改稿<br> 2020.6.09 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Tue Jun 09 21:59:43 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858357, encodeId=f58585835ecd, content=2019-12-4 投稿<br> 2019-12-24 审稿意见回来。三个审稿人,2个小修,一个拒稿,说创新性不足。编辑拒稿。<br> 2019-12-24 老板不服,上诉argue。<br> 2020-01-30 编辑回信,上诉成功,稿件状态由拒稿变为大修,给了10天修改时间,明确说还会 <br> 再次送审。<br> 2020-2-8 提交返修稿,按照审稿人要求修改了论文和补充了实验。<br> 2020-2-20 接受。不需要再修改。<br> 2020-3-6 proof<br> 2020-3-12 online<br> 总的来说,觉得自己文章有亮点,就要敢于争取。做的是介入光动力学治疗这一块的,希望大家多多引用(doi: 10.1002/adfm.201910084)。最后希望全世界的新冠疫情早点结束。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Mar 13 18:27:32 CST 2020, time=2020-03-13, status=1, ipAttribution=)]
    2021-06-01 ms3000001632795408

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:许个愿,有消息了会还愿
    3月5号,投稿
    4月29号,拒稿,建议转投
    5月23号,二投
    等待中

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1099067, encodeId=9120109906e7a, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099068, encodeId=180210990682c, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970108, encodeId=81979e01080e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:许个愿,有消息了会还愿<br>3月5号,投稿<br>4月29号,拒稿,建议转投<br>5月23号,二投<br>等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ebd35496006, createdName=ms3000001632795408, createdTime=Tue Jun 01 17:20:03 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013133, encodeId=b45910131332c, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:可穿戴能源;汗液;传感<br>经验分享:editor-in-chief: joern ritterbusch。。。确实,搞得同样的问题,十多天没送审,然后让转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06502182349, createdName=12076f1am80(暂无昵称), createdTime=Tue Aug 31 10:23:04 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859755, encodeId=3859859e5593, content=为什么你们效率都那么快,投了还有3个半小时就14天了,看经验原以为这么久差不多已经送审了,结果这快14天的时候编辑才来信建议转投。我吐了,我好难!编辑是editor-in-chief: joern ritterbusch。建议转投的期刊也是他是editor-in-chief,是新出的wiley期刊,if还没有。我哭辽。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Thu Apr 23 14:05:45 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861953, encodeId=658786195320, content=审稿速度:3.0<br>经验分享:投稿后14天送审,三个月后返回审稿意见,三个大修。两周后返回隔天接收。<br> 总体来讲afm喜欢追热点材料,对机理和创新性要求并不高,同级别里面,个人跟喜欢acs nano的质量。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Jun 16 04:55:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996459, encodeId=05279964597a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:5.20投稿(出审稿意见前,一直显示under consideration)<br>6.15返修(两个小修,一个大修,给10天修改)<br>6.24提交返修稿<br>7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d35541911, createdName=ms8000001728757183, createdTime=Mon Jul 05 16:26:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850962, encodeId=1bfc8509626c, content=18年12月底投am,1月8号建议转投afm<br> 转投后两个月审稿意见还没回来,写信催,告诉我还在审稿人手里<br> 3月12号被拒,一个vip,一个大修,一个拒稿,说我们没有创新,编辑拒稿<br> 申诉,一周后从拒稿转为大修,3月26号投出去,到现在还没有消息。。。<br> 只能说太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Mon Apr 22 10:53:02 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861652, encodeId=cb76861652c1, content=2020.5.15 投稿<br> 2020.6.02 出审稿意见,一大修,一小修,编辑给大修<br> 2020.6.07 提交修改稿<br> 2020.6.09 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Tue Jun 09 21:59:43 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858357, encodeId=f58585835ecd, content=2019-12-4 投稿<br> 2019-12-24 审稿意见回来。三个审稿人,2个小修,一个拒稿,说创新性不足。编辑拒稿。<br> 2019-12-24 老板不服,上诉argue。<br> 2020-01-30 编辑回信,上诉成功,稿件状态由拒稿变为大修,给了10天修改时间,明确说还会 <br> 再次送审。<br> 2020-2-8 提交返修稿,按照审稿人要求修改了论文和补充了实验。<br> 2020-2-20 接受。不需要再修改。<br> 2020-3-6 proof<br> 2020-3-12 online<br> 总的来说,觉得自己文章有亮点,就要敢于争取。做的是介入光动力学治疗这一块的,希望大家多多引用(doi: 10.1002/adfm.201910084)。最后希望全世界的新冠疫情早点结束。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Mar 13 18:27:32 CST 2020, time=2020-03-13, status=1, ipAttribution=)]
    2021-08-31 12076f1am80(暂无昵称)

    审稿速度:1.0 | 投稿命中率:5.0
    偏重的研究方向:可穿戴能源;汗液;传感
    经验分享:editor-in-chief: joern ritterbusch。。。确实,搞得同样的问题,十多天没送审,然后让转投

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1099067, encodeId=9120109906e7a, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099068, encodeId=180210990682c, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970108, encodeId=81979e01080e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:许个愿,有消息了会还愿<br>3月5号,投稿<br>4月29号,拒稿,建议转投<br>5月23号,二投<br>等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ebd35496006, createdName=ms3000001632795408, createdTime=Tue Jun 01 17:20:03 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013133, encodeId=b45910131332c, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:可穿戴能源;汗液;传感<br>经验分享:editor-in-chief: joern ritterbusch。。。确实,搞得同样的问题,十多天没送审,然后让转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06502182349, createdName=12076f1am80(暂无昵称), createdTime=Tue Aug 31 10:23:04 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859755, encodeId=3859859e5593, content=为什么你们效率都那么快,投了还有3个半小时就14天了,看经验原以为这么久差不多已经送审了,结果这快14天的时候编辑才来信建议转投。我吐了,我好难!编辑是editor-in-chief: joern ritterbusch。建议转投的期刊也是他是editor-in-chief,是新出的wiley期刊,if还没有。我哭辽。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Thu Apr 23 14:05:45 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861953, encodeId=658786195320, content=审稿速度:3.0<br>经验分享:投稿后14天送审,三个月后返回审稿意见,三个大修。两周后返回隔天接收。<br> 总体来讲afm喜欢追热点材料,对机理和创新性要求并不高,同级别里面,个人跟喜欢acs nano的质量。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Jun 16 04:55:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996459, encodeId=05279964597a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:5.20投稿(出审稿意见前,一直显示under consideration)<br>6.15返修(两个小修,一个大修,给10天修改)<br>6.24提交返修稿<br>7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d35541911, createdName=ms8000001728757183, createdTime=Mon Jul 05 16:26:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850962, encodeId=1bfc8509626c, content=18年12月底投am,1月8号建议转投afm<br> 转投后两个月审稿意见还没回来,写信催,告诉我还在审稿人手里<br> 3月12号被拒,一个vip,一个大修,一个拒稿,说我们没有创新,编辑拒稿<br> 申诉,一周后从拒稿转为大修,3月26号投出去,到现在还没有消息。。。<br> 只能说太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Mon Apr 22 10:53:02 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861652, encodeId=cb76861652c1, content=2020.5.15 投稿<br> 2020.6.02 出审稿意见,一大修,一小修,编辑给大修<br> 2020.6.07 提交修改稿<br> 2020.6.09 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Tue Jun 09 21:59:43 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858357, encodeId=f58585835ecd, content=2019-12-4 投稿<br> 2019-12-24 审稿意见回来。三个审稿人,2个小修,一个拒稿,说创新性不足。编辑拒稿。<br> 2019-12-24 老板不服,上诉argue。<br> 2020-01-30 编辑回信,上诉成功,稿件状态由拒稿变为大修,给了10天修改时间,明确说还会 <br> 再次送审。<br> 2020-2-8 提交返修稿,按照审稿人要求修改了论文和补充了实验。<br> 2020-2-20 接受。不需要再修改。<br> 2020-3-6 proof<br> 2020-3-12 online<br> 总的来说,觉得自己文章有亮点,就要敢于争取。做的是介入光动力学治疗这一块的,希望大家多多引用(doi: 10.1002/adfm.201910084)。最后希望全世界的新冠疫情早点结束。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Mar 13 18:27:32 CST 2020, time=2020-03-13, status=1, ipAttribution=)]
    2020-04-23 ms3908193925310106

    为什么你们效率都那么快,投了还有3个半小时就14天了,看经验原以为这么久差不多已经送审了,结果这快14天的时候编辑才来信建议转投。我吐了,我好难!编辑是editor-in-chief: joern ritterbusch。建议转投的期刊也是他是editor-in-chief,是新出的wiley期刊,if还没有。我哭辽。

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1099067, encodeId=9120109906e7a, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099068, encodeId=180210990682c, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970108, encodeId=81979e01080e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:许个愿,有消息了会还愿<br>3月5号,投稿<br>4月29号,拒稿,建议转投<br>5月23号,二投<br>等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ebd35496006, createdName=ms3000001632795408, createdTime=Tue Jun 01 17:20:03 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013133, encodeId=b45910131332c, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:可穿戴能源;汗液;传感<br>经验分享:editor-in-chief: joern ritterbusch。。。确实,搞得同样的问题,十多天没送审,然后让转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06502182349, createdName=12076f1am80(暂无昵称), createdTime=Tue Aug 31 10:23:04 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859755, encodeId=3859859e5593, content=为什么你们效率都那么快,投了还有3个半小时就14天了,看经验原以为这么久差不多已经送审了,结果这快14天的时候编辑才来信建议转投。我吐了,我好难!编辑是editor-in-chief: joern ritterbusch。建议转投的期刊也是他是editor-in-chief,是新出的wiley期刊,if还没有。我哭辽。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Thu Apr 23 14:05:45 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861953, encodeId=658786195320, content=审稿速度:3.0<br>经验分享:投稿后14天送审,三个月后返回审稿意见,三个大修。两周后返回隔天接收。<br> 总体来讲afm喜欢追热点材料,对机理和创新性要求并不高,同级别里面,个人跟喜欢acs nano的质量。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Jun 16 04:55:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996459, encodeId=05279964597a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:5.20投稿(出审稿意见前,一直显示under consideration)<br>6.15返修(两个小修,一个大修,给10天修改)<br>6.24提交返修稿<br>7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d35541911, createdName=ms8000001728757183, createdTime=Mon Jul 05 16:26:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850962, encodeId=1bfc8509626c, content=18年12月底投am,1月8号建议转投afm<br> 转投后两个月审稿意见还没回来,写信催,告诉我还在审稿人手里<br> 3月12号被拒,一个vip,一个大修,一个拒稿,说我们没有创新,编辑拒稿<br> 申诉,一周后从拒稿转为大修,3月26号投出去,到现在还没有消息。。。<br> 只能说太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Mon Apr 22 10:53:02 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861652, encodeId=cb76861652c1, content=2020.5.15 投稿<br> 2020.6.02 出审稿意见,一大修,一小修,编辑给大修<br> 2020.6.07 提交修改稿<br> 2020.6.09 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Tue Jun 09 21:59:43 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858357, encodeId=f58585835ecd, content=2019-12-4 投稿<br> 2019-12-24 审稿意见回来。三个审稿人,2个小修,一个拒稿,说创新性不足。编辑拒稿。<br> 2019-12-24 老板不服,上诉argue。<br> 2020-01-30 编辑回信,上诉成功,稿件状态由拒稿变为大修,给了10天修改时间,明确说还会 <br> 再次送审。<br> 2020-2-8 提交返修稿,按照审稿人要求修改了论文和补充了实验。<br> 2020-2-20 接受。不需要再修改。<br> 2020-3-6 proof<br> 2020-3-12 online<br> 总的来说,觉得自己文章有亮点,就要敢于争取。做的是介入光动力学治疗这一块的,希望大家多多引用(doi: 10.1002/adfm.201910084)。最后希望全世界的新冠疫情早点结束。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Mar 13 18:27:32 CST 2020, time=2020-03-13, status=1, ipAttribution=)]
    2020-06-16 ms8743830992601654

    审稿速度:3.0
    经验分享:投稿后14天送审,三个月后返回审稿意见,三个大修。两周后返回隔天接收。
    总体来讲afm喜欢追热点材料,对机理和创新性要求并不高,同级别里面,个人跟喜欢acs nano的质量。

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1099067, encodeId=9120109906e7a, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099068, encodeId=180210990682c, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970108, encodeId=81979e01080e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:许个愿,有消息了会还愿<br>3月5号,投稿<br>4月29号,拒稿,建议转投<br>5月23号,二投<br>等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ebd35496006, createdName=ms3000001632795408, createdTime=Tue Jun 01 17:20:03 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013133, encodeId=b45910131332c, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:可穿戴能源;汗液;传感<br>经验分享:editor-in-chief: joern ritterbusch。。。确实,搞得同样的问题,十多天没送审,然后让转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06502182349, createdName=12076f1am80(暂无昵称), createdTime=Tue Aug 31 10:23:04 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859755, encodeId=3859859e5593, content=为什么你们效率都那么快,投了还有3个半小时就14天了,看经验原以为这么久差不多已经送审了,结果这快14天的时候编辑才来信建议转投。我吐了,我好难!编辑是editor-in-chief: joern ritterbusch。建议转投的期刊也是他是editor-in-chief,是新出的wiley期刊,if还没有。我哭辽。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Thu Apr 23 14:05:45 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861953, encodeId=658786195320, content=审稿速度:3.0<br>经验分享:投稿后14天送审,三个月后返回审稿意见,三个大修。两周后返回隔天接收。<br> 总体来讲afm喜欢追热点材料,对机理和创新性要求并不高,同级别里面,个人跟喜欢acs nano的质量。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Jun 16 04:55:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996459, encodeId=05279964597a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:5.20投稿(出审稿意见前,一直显示under consideration)<br>6.15返修(两个小修,一个大修,给10天修改)<br>6.24提交返修稿<br>7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d35541911, createdName=ms8000001728757183, createdTime=Mon Jul 05 16:26:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850962, encodeId=1bfc8509626c, content=18年12月底投am,1月8号建议转投afm<br> 转投后两个月审稿意见还没回来,写信催,告诉我还在审稿人手里<br> 3月12号被拒,一个vip,一个大修,一个拒稿,说我们没有创新,编辑拒稿<br> 申诉,一周后从拒稿转为大修,3月26号投出去,到现在还没有消息。。。<br> 只能说太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Mon Apr 22 10:53:02 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861652, encodeId=cb76861652c1, content=2020.5.15 投稿<br> 2020.6.02 出审稿意见,一大修,一小修,编辑给大修<br> 2020.6.07 提交修改稿<br> 2020.6.09 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Tue Jun 09 21:59:43 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858357, encodeId=f58585835ecd, content=2019-12-4 投稿<br> 2019-12-24 审稿意见回来。三个审稿人,2个小修,一个拒稿,说创新性不足。编辑拒稿。<br> 2019-12-24 老板不服,上诉argue。<br> 2020-01-30 编辑回信,上诉成功,稿件状态由拒稿变为大修,给了10天修改时间,明确说还会 <br> 再次送审。<br> 2020-2-8 提交返修稿,按照审稿人要求修改了论文和补充了实验。<br> 2020-2-20 接受。不需要再修改。<br> 2020-3-6 proof<br> 2020-3-12 online<br> 总的来说,觉得自己文章有亮点,就要敢于争取。做的是介入光动力学治疗这一块的,希望大家多多引用(doi: 10.1002/adfm.201910084)。最后希望全世界的新冠疫情早点结束。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Mar 13 18:27:32 CST 2020, time=2020-03-13, status=1, ipAttribution=)]
    2021-07-05 ms8000001728757183

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:5.20投稿(出审稿意见前,一直显示under consideration)
    6.15返修(两个小修,一个大修,给10天修改)
    6.24提交返修稿
    7.5接受

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1099067, encodeId=9120109906e7a, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099068, encodeId=180210990682c, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970108, encodeId=81979e01080e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:许个愿,有消息了会还愿<br>3月5号,投稿<br>4月29号,拒稿,建议转投<br>5月23号,二投<br>等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ebd35496006, createdName=ms3000001632795408, createdTime=Tue Jun 01 17:20:03 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013133, encodeId=b45910131332c, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:可穿戴能源;汗液;传感<br>经验分享:editor-in-chief: joern ritterbusch。。。确实,搞得同样的问题,十多天没送审,然后让转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06502182349, createdName=12076f1am80(暂无昵称), createdTime=Tue Aug 31 10:23:04 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859755, encodeId=3859859e5593, content=为什么你们效率都那么快,投了还有3个半小时就14天了,看经验原以为这么久差不多已经送审了,结果这快14天的时候编辑才来信建议转投。我吐了,我好难!编辑是editor-in-chief: joern ritterbusch。建议转投的期刊也是他是editor-in-chief,是新出的wiley期刊,if还没有。我哭辽。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Thu Apr 23 14:05:45 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861953, encodeId=658786195320, content=审稿速度:3.0<br>经验分享:投稿后14天送审,三个月后返回审稿意见,三个大修。两周后返回隔天接收。<br> 总体来讲afm喜欢追热点材料,对机理和创新性要求并不高,同级别里面,个人跟喜欢acs nano的质量。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Jun 16 04:55:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996459, encodeId=05279964597a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:5.20投稿(出审稿意见前,一直显示under consideration)<br>6.15返修(两个小修,一个大修,给10天修改)<br>6.24提交返修稿<br>7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d35541911, createdName=ms8000001728757183, createdTime=Mon Jul 05 16:26:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850962, encodeId=1bfc8509626c, content=18年12月底投am,1月8号建议转投afm<br> 转投后两个月审稿意见还没回来,写信催,告诉我还在审稿人手里<br> 3月12号被拒,一个vip,一个大修,一个拒稿,说我们没有创新,编辑拒稿<br> 申诉,一周后从拒稿转为大修,3月26号投出去,到现在还没有消息。。。<br> 只能说太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Mon Apr 22 10:53:02 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861652, encodeId=cb76861652c1, content=2020.5.15 投稿<br> 2020.6.02 出审稿意见,一大修,一小修,编辑给大修<br> 2020.6.07 提交修改稿<br> 2020.6.09 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Tue Jun 09 21:59:43 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858357, encodeId=f58585835ecd, content=2019-12-4 投稿<br> 2019-12-24 审稿意见回来。三个审稿人,2个小修,一个拒稿,说创新性不足。编辑拒稿。<br> 2019-12-24 老板不服,上诉argue。<br> 2020-01-30 编辑回信,上诉成功,稿件状态由拒稿变为大修,给了10天修改时间,明确说还会 <br> 再次送审。<br> 2020-2-8 提交返修稿,按照审稿人要求修改了论文和补充了实验。<br> 2020-2-20 接受。不需要再修改。<br> 2020-3-6 proof<br> 2020-3-12 online<br> 总的来说,觉得自己文章有亮点,就要敢于争取。做的是介入光动力学治疗这一块的,希望大家多多引用(doi: 10.1002/adfm.201910084)。最后希望全世界的新冠疫情早点结束。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Mar 13 18:27:32 CST 2020, time=2020-03-13, status=1, ipAttribution=)]
    2019-04-22 ms8743830992601654

    18年12月底投am,1月8号建议转投afm
    转投后两个月审稿意见还没回来,写信催,告诉我还在审稿人手里
    3月12号被拒,一个vip,一个大修,一个拒稿,说我们没有创新,编辑拒稿
    申诉,一周后从拒稿转为大修,3月26号投出去,到现在还没有消息。。。
    只能说太慢了

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1099067, encodeId=9120109906e7a, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099068, encodeId=180210990682c, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970108, encodeId=81979e01080e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:许个愿,有消息了会还愿<br>3月5号,投稿<br>4月29号,拒稿,建议转投<br>5月23号,二投<br>等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ebd35496006, createdName=ms3000001632795408, createdTime=Tue Jun 01 17:20:03 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013133, encodeId=b45910131332c, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:可穿戴能源;汗液;传感<br>经验分享:editor-in-chief: joern ritterbusch。。。确实,搞得同样的问题,十多天没送审,然后让转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06502182349, createdName=12076f1am80(暂无昵称), createdTime=Tue Aug 31 10:23:04 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859755, encodeId=3859859e5593, content=为什么你们效率都那么快,投了还有3个半小时就14天了,看经验原以为这么久差不多已经送审了,结果这快14天的时候编辑才来信建议转投。我吐了,我好难!编辑是editor-in-chief: joern ritterbusch。建议转投的期刊也是他是editor-in-chief,是新出的wiley期刊,if还没有。我哭辽。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Thu Apr 23 14:05:45 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861953, encodeId=658786195320, content=审稿速度:3.0<br>经验分享:投稿后14天送审,三个月后返回审稿意见,三个大修。两周后返回隔天接收。<br> 总体来讲afm喜欢追热点材料,对机理和创新性要求并不高,同级别里面,个人跟喜欢acs nano的质量。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Jun 16 04:55:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996459, encodeId=05279964597a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:5.20投稿(出审稿意见前,一直显示under consideration)<br>6.15返修(两个小修,一个大修,给10天修改)<br>6.24提交返修稿<br>7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d35541911, createdName=ms8000001728757183, createdTime=Mon Jul 05 16:26:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850962, encodeId=1bfc8509626c, content=18年12月底投am,1月8号建议转投afm<br> 转投后两个月审稿意见还没回来,写信催,告诉我还在审稿人手里<br> 3月12号被拒,一个vip,一个大修,一个拒稿,说我们没有创新,编辑拒稿<br> 申诉,一周后从拒稿转为大修,3月26号投出去,到现在还没有消息。。。<br> 只能说太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Mon Apr 22 10:53:02 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861652, encodeId=cb76861652c1, content=2020.5.15 投稿<br> 2020.6.02 出审稿意见,一大修,一小修,编辑给大修<br> 2020.6.07 提交修改稿<br> 2020.6.09 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Tue Jun 09 21:59:43 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858357, encodeId=f58585835ecd, content=2019-12-4 投稿<br> 2019-12-24 审稿意见回来。三个审稿人,2个小修,一个拒稿,说创新性不足。编辑拒稿。<br> 2019-12-24 老板不服,上诉argue。<br> 2020-01-30 编辑回信,上诉成功,稿件状态由拒稿变为大修,给了10天修改时间,明确说还会 <br> 再次送审。<br> 2020-2-8 提交返修稿,按照审稿人要求修改了论文和补充了实验。<br> 2020-2-20 接受。不需要再修改。<br> 2020-3-6 proof<br> 2020-3-12 online<br> 总的来说,觉得自己文章有亮点,就要敢于争取。做的是介入光动力学治疗这一块的,希望大家多多引用(doi: 10.1002/adfm.201910084)。最后希望全世界的新冠疫情早点结束。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Mar 13 18:27:32 CST 2020, time=2020-03-13, status=1, ipAttribution=)]
    2020-06-09 ms7269483029162029

    2020.5.15 投稿
    2020.6.02 出审稿意见,一大修,一小修,编辑给大修
    2020.6.07 提交修改稿
    2020.6.09 接收

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1099067, encodeId=9120109906e7a, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099068, encodeId=180210990682c, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970108, encodeId=81979e01080e, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:许个愿,有消息了会还愿<br>3月5号,投稿<br>4月29号,拒稿,建议转投<br>5月23号,二投<br>等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ebd35496006, createdName=ms3000001632795408, createdTime=Tue Jun 01 17:20:03 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013133, encodeId=b45910131332c, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:可穿戴能源;汗液;传感<br>经验分享:editor-in-chief: joern ritterbusch。。。确实,搞得同样的问题,十多天没送审,然后让转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06502182349, createdName=12076f1am80(暂无昵称), createdTime=Tue Aug 31 10:23:04 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859755, encodeId=3859859e5593, content=为什么你们效率都那么快,投了还有3个半小时就14天了,看经验原以为这么久差不多已经送审了,结果这快14天的时候编辑才来信建议转投。我吐了,我好难!编辑是editor-in-chief: joern ritterbusch。建议转投的期刊也是他是editor-in-chief,是新出的wiley期刊,if还没有。我哭辽。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Thu Apr 23 14:05:45 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861953, encodeId=658786195320, content=审稿速度:3.0<br>经验分享:投稿后14天送审,三个月后返回审稿意见,三个大修。两周后返回隔天接收。<br> 总体来讲afm喜欢追热点材料,对机理和创新性要求并不高,同级别里面,个人跟喜欢acs nano的质量。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Jun 16 04:55:26 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996459, encodeId=05279964597a, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:5.20投稿(出审稿意见前,一直显示under consideration)<br>6.15返修(两个小修,一个大修,给10天修改)<br>6.24提交返修稿<br>7.5接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d35541911, createdName=ms8000001728757183, createdTime=Mon Jul 05 16:26:27 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850962, encodeId=1bfc8509626c, content=18年12月底投am,1月8号建议转投afm<br> 转投后两个月审稿意见还没回来,写信催,告诉我还在审稿人手里<br> 3月12号被拒,一个vip,一个大修,一个拒稿,说我们没有创新,编辑拒稿<br> 申诉,一周后从拒稿转为大修,3月26号投出去,到现在还没有消息。。。<br> 只能说太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Mon Apr 22 10:53:02 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861652, encodeId=cb76861652c1, content=2020.5.15 投稿<br> 2020.6.02 出审稿意见,一大修,一小修,编辑给大修<br> 2020.6.07 提交修改稿<br> 2020.6.09 接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Tue Jun 09 21:59:43 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858357, encodeId=f58585835ecd, content=2019-12-4 投稿<br> 2019-12-24 审稿意见回来。三个审稿人,2个小修,一个拒稿,说创新性不足。编辑拒稿。<br> 2019-12-24 老板不服,上诉argue。<br> 2020-01-30 编辑回信,上诉成功,稿件状态由拒稿变为大修,给了10天修改时间,明确说还会 <br> 再次送审。<br> 2020-2-8 提交返修稿,按照审稿人要求修改了论文和补充了实验。<br> 2020-2-20 接受。不需要再修改。<br> 2020-3-6 proof<br> 2020-3-12 online<br> 总的来说,觉得自己文章有亮点,就要敢于争取。做的是介入光动力学治疗这一块的,希望大家多多引用(doi: 10.1002/adfm.201910084)。最后希望全世界的新冠疫情早点结束。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Fri Mar 13 18:27:32 CST 2020, time=2020-03-13, status=1, ipAttribution=)]
    2020-03-13 ms903640464789830

    2019-12-4 投稿
    2019-12-24 审稿意见回来。三个审稿人,2个小修,一个拒稿,说创新性不足。编辑拒稿。
    2019-12-24 老板不服,上诉argue。
    2020-01-30 编辑回信,上诉成功,稿件状态由拒稿变为大修,给了10天修改时间,明确说还会
    再次送审。
    2020-2-8 提交返修稿,按照审稿人要求修改了论文和补充了实验。
    2020-2-20 接受。不需要再修改。
    2020-3-6 proof
    2020-3-12 online
    总的来说,觉得自己文章有亮点,就要敢于争取。做的是介入光动力学治疗这一块的,希望大家多多引用(doi: 10.1002/adfm.201910084)。最后希望全世界的新冠疫情早点结束。

    1

    展开1条回复
共125条页码: 2/13页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分